Asma Hallab

Asma Hallab

Auto-generated profile, based on publicly available information

Asma Hallab

Department of Psychiatry and Psychotherapy, Otto-von-Guericke University of Medicine, University Hospital of Magdeburg, Magdeburg, Germany

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
MMMostafa Ebraheem Morra
Mostafa Ebraheem Morra
AAAhmed M.A. Altibi
Ahmed M.A. Altibi
SISomia Iqtadar
Somia Iqtadar
Minh H. N. LeMinh H. N. Le
Minh H. N. Le
SESameh Samir Elawady
Sameh Samir Elawady
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy
1

1 February 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JTJennifer Thorpe
Jennifer Thorpe
SASamantha Ashby
Samantha Ashby
AHAsma Hallab
Asma Hallab
DDDing Ding
Ding Ding
MAMaria Andraus
Maria Andraus
Arjune SenArjune Sen
Arjune Sen

1 January 2018 in General Hospital Psychiatry
Verified
Journal Article
Closed access
AHAsma Hallab
Asma Hallab
SNSadiq Naveed
Sadiq Naveed
AAAhmed Altibi
Ahmed Altibi
MAMariam Abdelkhalek
Mariam Abdelkhalek
HNHuyen Thi Ngo
Huyen Thi Ngo
Nguyen Tien HuyNguyen Tien Huy
Nguyen Tien Huy

9 August 2021 in Epilepsy & Behavior
Verified
Journal Article
Closed access
MAMaria Andraus
Maria Andraus
JTJennifer Thorpe
Jennifer Thorpe
XTXin You Tai
Xin You Tai
SASamantha Ashby
Samantha Ashby
AHAsma Hallab
Asma Hallab
Arjune SenArjune Sen
Arjune Sen

1 November 2021 in Seizure: European Journal of Epilepsy
Verified
Journal Article
Closed access
AHAsma Hallab
Asma Hallab
Arjune SenArjune Sen
Arjune Sen

28 September 2024 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
AHAsma Hallab
Asma Hallab
FIFor The Alzheimer’s Disease Neuroimaging Initiative
For The Alzheimer’s Disease Neuroimaging Initiative
Introduction: Sleep disorders, particularly insomnia and obstructive sleep apnea, are associated with dyslipidemia in the general population. The study’s aim was to explore the association between pathological Cholesterol and Triglyceride levels, and sleep and nighttime behavior disorders (SNBD) in older adults, whether they might predict SNBD onset, and to emphasize the role of body mass index (BMI) in this association. Methods: Alzheimer’s Disease Neuroimaging Initiative (ADNI) population with complete Cholesterol, Triglyceride, SNBD, and neurocognitive data were included. Logistic regression was performed to study the association between hypercholesterolemia, hypertriglyceridemia, and SNBD at baseline and at 12 months. Relevant confounders, particularly BMI, were adjusted for. Results: Among the 2,216 included cases, 1,045 (47%) were females, and the median age was 73 years (IQR: 68, 78). At baseline, 357 (16%) had SNBD and 327 (18%) at 12 months; 187 of them were incident cases. There were more cases of baseline SNBD in the hypertriglyceridemia group than in those without (19% vs. 14%, P-value = 0.003). Similarly, more follow-up SNBD cases had hypertriglyceridemia at baseline (21% vs. 16%, P-value = 0.025). SNBD cases at baseline had significantly higher serum Triglyceride levels than those without (132 vs. 118mg/dL, P-value < 0.001). Only hypertriglyceridemia was significantly associated with baseline SNBD (crude OR = 1.43, 95%CI: 1.13,1.80, P-value = 0.003), even after adjustment for confounding factors (adj. OR = 1.36, 95%CI: 1.06,1.74, P-value = 0.016) and (BMI-adj. OR = 1.29, 95%CI: 1.00,1.66, P-value = 0.048). None of the dyslipidemia forms did predict incident cases at 12 months. Conclusions: Hypertriglyceridemia, but not hypercholesterolemia, was associated with higher odds of SNBD. The association was independent of BMI. None of the dyslipidemia forms did predict incident SNBD over 12 months. Sleep disorders should motivate a systematic screening of dyslipidemia in older adults and vice versa.